MML Investors Services LLC Raises Stock Position in IQVIA Holdings Inc. (NYSE:IQV)

MML Investors Services LLC boosted its stake in shares of IQVIA Holdings Inc. (NYSE:IQV) by 6.3% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 134,396 shares of the medical research company’s stock after purchasing an additional 7,980 shares during the period. MML Investors Services LLC owned approximately 0.07% of IQVIA worth $31,848,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Tenere Capital LLC purchased a new position in IQVIA during the third quarter worth approximately $14,896,000. Orion Portfolio Solutions LLC raised its stake in shares of IQVIA by 2.3% during the 3rd quarter. Orion Portfolio Solutions LLC now owns 16,319 shares of the medical research company’s stock worth $3,867,000 after buying an additional 364 shares during the period. iSAM Funds UK Ltd grew its stake in IQVIA by 28.3% in the 3rd quarter. iSAM Funds UK Ltd now owns 2,576 shares of the medical research company’s stock valued at $610,000 after acquiring an additional 568 shares during the period. National Bank of Canada FI increased its holdings in IQVIA by 245.0% in the 3rd quarter. National Bank of Canada FI now owns 181,423 shares of the medical research company’s stock worth $42,992,000 after acquiring an additional 128,843 shares in the last quarter. Finally, Voya Financial Advisors Inc. raised its position in IQVIA by 0.6% during the third quarter. Voya Financial Advisors Inc. now owns 12,272 shares of the medical research company’s stock worth $2,881,000 after acquiring an additional 73 shares during the period. Hedge funds and other institutional investors own 89.62% of the company’s stock.

IQVIA Stock Up 1.4 %

IQV opened at $202.63 on Monday. The stock has a market capitalization of $36.78 billion, a P/E ratio of 26.59, a price-to-earnings-growth ratio of 2.08 and a beta of 1.49. The company has a debt-to-equity ratio of 1.76, a quick ratio of 0.81 and a current ratio of 0.81. IQVIA Holdings Inc. has a one year low of $187.62 and a one year high of $261.73. The business’s 50-day simple moving average is $215.18 and its 200-day simple moving average is $225.10.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on IQV. Morgan Stanley cut their target price on shares of IQVIA from $280.00 to $265.00 and set an “overweight” rating for the company in a research note on Monday, November 4th. Truist Financial reduced their target price on IQVIA from $286.00 to $265.00 and set a “buy” rating for the company in a report on Monday, November 4th. StockNews.com lowered IQVIA from a “buy” rating to a “hold” rating in a research note on Thursday, November 28th. Evercore ISI reduced their price objective on IQVIA from $270.00 to $265.00 and set an “outperform” rating for the company in a research note on Tuesday, October 8th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and set a $270.00 target price on shares of IQVIA in a research note on Wednesday, December 4th. Five investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, IQVIA has an average rating of “Moderate Buy” and a consensus price target of $256.50.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.